Načítá se...
Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer
The Hepatocyte growth factor (HGF)—mesenchymal-epithelial transition (MET) pathway is deregulated in several cancers and is associated with aggressive phenotype and worse prognosis. MET, a tyrosine kinase receptor activated by HGF, plays a physiological role in embryogenesis, promoting cell growth,...
Uloženo v:
| Vydáno v: | Biomedicines |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344276/ https://ncbi.nlm.nih.gov/pubmed/28548075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines2040345 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|